Results 101 to 110 of about 10,158,480 (212)

Successful endoscopic sclerotherapy for anastomotic tumor hemorrhage: A case report

open access: yesDEN Open
A 71‐year‐old male developed anastomotic tumor bleeding after subtotal gastrectomy (Billroth II), and the surgery was refused due to coronary atherosclerotic heart disease.
Jinfeng Ren   +5 more
doaj   +1 more source

Tranexamic Acid in the Management of Non-variceal Upper Gastrointestinal Bleeding

open access: yesThe Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy
Background: Non-variceal upper gastrointestinal bleeding (UGIB) is a common case of emergency in daily clinical practice with a fairly high mortality rate.
Muhammad Reza, Saskia Aziza Nursyirwan
doaj   +1 more source

Chronic Liver Disease Self‐Management for Veterans: A Feasibility Trial

open access: yesLifestyle Medicine, Volume 7, Issue 4, October 2026.
ABSTRACT Background Rates of chronic liver disease (CLD) related to obesity and other cardiometabolic risk factors have increased dramatically and contribute to significant health burden and mortality. Lifestyle modification is commonly recommended, with a focus on nutrition, exercise, medication adherence, screening for CLD complications, and active ...
Carol Gonzalez   +3 more
wiley   +1 more source

Predictors of Emergency Blood Transfusion in Esophageal Variceal Bleeding

open access: yes, 2014
Objective: Esophageal variceal bleeding is the most important and common complication of cirrhosis. Predicting the indication of emergency transfusion in patients with esophageal variceal hemorrhage is controversial.
Ozturk, Engin   +6 more
core   +1 more source

NON-INVASIVE RADIOLOGICAL PREDICTORS OF PORTAL HYPERTENSION AND VARICEAL BLEEDING IN CHRONIC LIVER DISEASE PATIENTS: A PROSPECTIVE COHORT STUDY AT HAYATABAD MEDICAL COMPLEX, PESHAWAR

open access: yesPakistan Journal of Medicine and Dentistry
Background: Portal hypertension and variceal bleeding are leading causes of morbidity and mortality in chronic liver disease (CLD). Invasive tools remain the gold standard for risk assessment, but resource and patient constraints demand validated, non ...
Hadia Gul   +4 more
doaj   +1 more source

Long‐Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long‐Term Safety Extension

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1083-1096, October 2026.
In the POISE open‐label extension, patients with primary biliary cholangitis with inadequate response or intolerance to ursodeoxycholic acid received long‐term obeticholic acid (OCA) treatment. Findings demonstrated a safety profile consistent with the known characteristics of OCA, with no unexpected safety signals, while supporting sustained efficacy ...
Christopher L. Bowlus   +8 more
wiley   +1 more source

Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 7, Page 897-918, October 2026.
Individualized assessment identifies patients with decompensated autoimmune hepatitis cirrhosis who are likely to benefit from a time‐limited trial of immunosuppression versus those requiring immediate liver transplant evaluation. Early objective response monitoring (bilirubin, MELD‐Na and AST/ALT) guides continuation of immunosuppression, promotes ...
Pedro Robson Costa Passos   +2 more
wiley   +1 more source

TIPS in the Treatment of Variceal Bleeding

open access: yes, 2017
Variceal bleeding is a life-threatening complication of portal hypertension. In recent years, transjugular intrahepatic portosystemic shunt (TIPS) creation has cemented a role in the management of acute refractory bleeding and recurrent variceal ...
Andrew Lipnik, Joseph Morrison, Ron Gaba
core   +1 more source

Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity

open access: yesJournal of Internal Medicine, Volume 300, Issue 4, Page 513-527, October 2026.
Abstract Background Liver cirrhosis (LC) is frequently complicated by adrenal dysfunction; however, whether cirrhosis drives the coordinated, pathway‐specific reprogramming of cortisol metabolism remains unclear. Objectives We aimed to characterize axis‐specific alterations in cortisol metabolism in patients with LC, those with adrenal insufficiency ...
Soyeon Park   +8 more
wiley   +1 more source

Risk factors for Variceal Bleeding

open access: yes, 1999
Variceal bleeding is the most serious complication of portal hypertension.  It is seen in 50-60% of patients with cirrhosis.  The mortality in patients wo develop gastroesophageal variceal bleeding is approximately one third.
Arnaout, Angel
core   +1 more source

Home - About - Disclaimer - Privacy